Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Atea Pharmaceuticals (AVIR) Current Assets (2020 - 2022)

Atea Pharmaceuticals (AVIR) has 3 years of Current Assets data on record, last reported at $681.9 million in Q3 2022.

  • For Q3 2022, Current Assets fell 19.1% year-over-year to $681.9 million; the TTM value through Sep 2022 reached $681.9 million, down 19.1%, while the annual FY2021 figure was $772.4 million, 10.55% down from the prior year.
  • Current Assets reached $681.9 million in Q3 2022 per AVIR's latest filing, down from $689.5 million in the prior quarter.
  • Across five years, Current Assets topped out at $871.1 million in Q2 2021 and bottomed at $108.4 million in Q3 2020.
  • Average Current Assets over 3 years is $709.2 million, with a median of $772.4 million recorded in 2021.
  • Peak YoY movement for Current Assets: soared 677.53% in 2021, then fell 20.85% in 2022.
  • A 3-year view of Current Assets shows it stood at $863.5 million in 2020, then dropped by 10.55% to $772.4 million in 2021, then dropped by 11.71% to $681.9 million in 2022.
  • Per Business Quant database, its latest 3 readings for Current Assets were $681.9 million in Q3 2022, $689.5 million in Q2 2022, and $713.2 million in Q1 2022.